THESEUS PHARMACEUTICALS, INC.
CIK 0001745020
Revenue (TTM)
—
Q3 Nov 2023
Net Income (TTM)
−$57.64M
−85.3% YoY
Q3 Nov 2023
EPS Diluted (TTM)
−$1.37
+53.9% YoY
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
—
Q3 Nov 2023
Net Margin
—
Q3 Nov 2023
Free Cash Flow (TTM)
−$33.4M
Q3 Nov 2023
Cash
$46.89M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
44.23M sh
Q3 Nov 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.